1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. LBX Pharmacy Chain Joint Stock Company
  6. News
  7. Summary
    603883   CNE1000023Q8

LBX PHARMACY CHAIN JOINT STOCK COMPANY

(603883)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-18
36.24 CNY   +2.20%
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a 71.9% stake in Hunan Huairen Great Health Industry Development Co., Ltd. from group of sellers for CNY 1.6 billion.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

LBX Pharmacy Chain Joint Stock Company completed the acquisition of the remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. from Hu Jianzhong.

09/30/2021 EDT

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) agreed to acquire remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. from Hu Jianzhong for CNY 36.3 million on July 16, 2021. The purchase price is payable in cash. As part of transaction, the transfer of creditor's rights and debts will not be involved. In related transactions, LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 49% stake in Jiangsu Baijiahui Suhe Pharmacy Chain Co., Ltd. and Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. Post-closing, LBX Pharmacy Chain Joint Stock Company will hold 100% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. The transaction is subject to approvals from the shareholders of LBX Pharmacy Chain Joint Stock Company and other possible approvals. On July 16, 2021, the transaction was approved unanimously by the Board of Directors of LBX Pharmacy Chain Joint Stock Company. As of August 20, 2021, shareholders of LBX Pharmacy Chain Joint Stock Company has approved the transaction. Ding Shaobo of Hunan Qiyuan Law Firm acted as the legal advisor, Li Dan of PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) and Hu Shaoxian of Pan-China Certified Public Accountants acted as an accountant, Wei Qinghua of Dongxing Securities Co., Ltd. acted as the financial advisor and China Swiss World Union Assets Appraisal Group Co., Ltd. and Hu Jiahao, He Yuanquan and Xie Songsha of Zhongrui Shilian Assets Appraisal Group Co., Ltd. acted as the appraisers for LBX Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company (SHSE:603883) completed the acquisition of the remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. from Hu Jianzhong on September 30, 2021.


© S&P Capital IQ 2021
All news about LBX PHARMACY CHAIN JOINT STOCK COMPANY
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended..
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter E..
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a ..
CI
03/06LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei ..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months End..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of the remaining 35% s..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company agreed to acquire 51% stake in Hebei Hua Tuo Pha..
CI
2021Lbx Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended..
CI
More news
Financials
Sales 2022 18 486 M 2 737 M 2 737 M
Net income 2022 798 M 118 M 118 M
Net Debt 2022 1 649 M 244 M 244 M
P/E ratio 2022 19,4x
Yield 2022 1,09%
Capitalization 16 169 M 2 394 M 2 394 M
EV / Sales 2022 0,96x
EV / Sales 2023 0,87x
Nbr of Employees -
Free-Float 45,5%
Chart LBX PHARMACY CHAIN JOINT STOCK COMPANY
Duration : Period :
LBX Pharmacy Chain Joint Stock Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LBX PHARMACY CHAIN JOINT STOCK COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 36,24 CNY
Average target price 59,92 CNY
Spread / Average Target 65,3%
EPS Revisions
Managers and Directors
Li Wang President
Jing Yang Zhu Chief Financial Officer
Zi Long Xie Chairman
Cheng Xiang Wang Chairman-Supervisory Board
Zhe Min Dan Independent Director
Sector and Competitors